Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Executive function is associated with brain proton magnetic resonance spectroscopy in amnestic mild cognitive impairment.

Griffith HR, Hollander JA, Okonkwo O, Evanochko WT, Harrell LE, Zamrini EY, Brockington JC, Marson DC.

J Clin Exp Neuropsychol. 2007 Aug;29(6):599-609.

PMID:
17691032
3.

Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.

Rami L, Gómez-Ansón B, Bosch B, Sánchez-Valle R, Monte GC, Villar A, Molinuevo JL.

Dement Geriatr Cogn Disord. 2007;24(4):274-9. Epub 2007 Aug 23.

PMID:
17717413
4.

A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease.

Shinno H, Inagaki T, Miyaoka T, Okazaki S, Kawamukai T, Utani E, Inami Y, Horiguchi J.

J Neurol Sci. 2007 Sep 15;260(1-2):132-8. Epub 2007 May 30.

PMID:
17540407
5.

Longitudinal metabolic and cognitive changes in mild cognitive impairment patients.

Olson BL, Holshouser BA, Britt W 3rd, Mueller C, Baqai W, Patra S, Petersen F, Kirsch WM.

Alzheimer Dis Assoc Disord. 2008 Jul-Sep;22(3):269-77. doi: 10.1097/WAD.0b013e3181750a65.

PMID:
18580584
6.

Brain metabolic correlates of decision making in amnestic mild cognitive impairment.

Griffith HR, Okonkwo OC, den Hollander JA, Belue K, Copeland J, Harrell LE, Brockington JC, Clark DG, Marson DC.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2010;17(4):492-504. doi: 10.1080/13825581003646135. Epub 2010 Apr 6.

7.

Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.

Zimny A, Szewczyk P, Trypka E, Wojtynska R, Noga L, Leszek J, Sasiadek M.

J Alzheimers Dis. 2011;27(3):591-601. doi: 10.3233/JAD-2011-110254.

PMID:
21841260
8.

Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.

Kantarci K, Petersen RC, Przybelski SA, Weigand SD, Shiung MM, Whitwell JL, Negash S, Ivnik RJ, Boeve BF, Knopman DS, Smith GE, Jack CR Jr.

Arch Neurol. 2008 Dec;65(12):1621-8. doi: 10.1001/archneur.65.12.1621.

9.

Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.

Griffith HR, den Hollander JA, Stewart CC, Evanochko WT, Buchthal SD, Harrell LE, Zamrini EY, Brockington JC, Marson DC.

NMR Biomed. 2007 Dec;20(8):709-16.

PMID:
17295394
10.

Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.

Ding B, Chen KM, Ling HW, Zhang H, Chai WM, Li X, Wang T.

Dement Geriatr Cogn Disord. 2008;25(3):218-25. doi: 10.1159/000113948. Epub 2008 Jan 25.

PMID:
18219201
11.

Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.

Lim TS, Hong YH, Lee HY, Choi JY, Kim HS, Moon SY.

Dement Geriatr Cogn Disord. 2012;33(2-3):149-55. doi: 10.1159/000338177. Epub 2012 May 7.

PMID:
22722669
12.

Improved myo-inositol detection through Carr-Purcell PRESS: a tool for more sensitive mild cognitive impairment diagnosis.

Hancu I, Gillen R, Cowan J, Zimmerman EA.

Magn Reson Med. 2011 Jun;65(6):1515-21. doi: 10.1002/mrm.22749. Epub 2011 Jan 10.

13.

Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.

Mohamed MA, Barker PB, Skolasky RL, Selnes OA, Moxley RT, Pomper MG, Sacktor NC.

Magn Reson Imaging. 2010 Nov;28(9):1251-7. doi: 10.1016/j.mri.2010.06.007. Epub 2010 Aug 4.

14.

Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.

Yang ZX, Huo SS, Cheng XF, Xu ZF, Cao Z, Zeng JX, Xiao YY, You KZ, Chen W, Liu YY, Wu RH.

Neuroradiology. 2012 May;54(5):451-8. doi: 10.1007/s00234-011-0900-0. Epub 2011 Jul 8.

PMID:
21739221
15.

Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.

García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.

Dement Geriatr Cogn Disord. 2008;26(1):15-25. doi: 10.1159/000140624. Epub 2008 Jun 20.

PMID:
18566544
16.

Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.

Metastasio A, Rinaldi P, Tarducci R, Mariani E, Feliziani FT, Cherubini A, Pelliccioli GP, Gobbi G, Senin U, Mecocci P.

Neurobiol Aging. 2006 Jul;27(7):926-32. Epub 2005 Jun 4.

PMID:
15936850
17.

Evaluation of functional MRI markers in mild cognitive impairment.

Zhang B, Li M, Sun ZZ, Zhu B, Yuan L, Wang Y, Xu Y.

J Clin Neurosci. 2009 May;16(5):635-41. doi: 10.1016/j.jocn.2008.07.080. Epub 2009 Mar 4.

PMID:
19264490
18.

Level of executive function influences verbal memory in amnestic mild cognitive impairment and predicts prefrontal and posterior cingulate thickness.

Chang YL, Jacobson MW, Fennema-Notestine C, Hagler DJ Jr, Jennings RG, Dale AM, McEvoy LK; Alzheimer's Disease Neuroimaging Initiative.

Cereb Cortex. 2010 Jun;20(6):1305-13. doi: 10.1093/cercor/bhp192. Epub 2009 Sep 23.

19.

Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment.

Zhu X, Cao L, Hu X, Dong Y, Wang H, Liu F, Sun Z.

Clin Neurol Neurosurg. 2015 Mar;130:80-5. doi: 10.1016/j.clineuro.2014.12.005. Epub 2014 Dec 26.

PMID:
25590663
20.

Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder.

Davanzo P, Thomas MA, Yue K, Oshiro T, Belin T, Strober M, McCracken J.

Neuropsychopharmacology. 2001 Apr;24(4):359-69.

Supplemental Content

Support Center